Informação sobre produto
- (2Z)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide
- 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-, (2Z)-
Afatinib is a potent, selective, and ATP-competitive inhibitor of EGFR. It blocks the phosphorylation of tyrosine residues on the extracellular domain of EGFR, thereby inhibiting receptor activation and causing inhibition of tumor cell proliferation in vitro and in vivo. Afatinib has been used as a research tool to study the function and regulation of EGFR signaling pathways. Afatinib has also been shown to block activation of the human transient receptor potential channel TRPM8 by menthol, which may be due to its ability to inhibit protein interactions with the channel.
Propriedades químicas
Consulta técnica sobre: 3D-FSC18459 (2Z)-Afatinib
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
